3P Biopharmaceuticals increases its microbial production capacity with the installation of a 500 L fermenter.
News and updates
News
3P Biopharmaceuticals among the 500 fastest growing companies in Spain
3P Biopharmaceuticals brings together leading international experts in biomedicine to celebrate its 15th anniversary.
Osivax and 3P Biopharmaceuticals team up to develop a new universal vaccine against current and future variants of SARS-COV-2
BrainEver and 3P Biopharmaceuticals collaborate on development of recombinant human homeoprotein Engrailed-1
3P Biopharmaceuticals among the 100 best companies to work for in Spain
3P Biopharmaceuticals celebrates its 15th anniversary with Juan Carlos Unzué.
3P Biopharmaceuticals and Biosergen complete together the manufacture of biomass for the Mucormycosis “Black Fungus” clinical phase II trial.
3P Biopharmaceuticals awards prize for the best Final Degree Project in Pharmacy at the University of Navarra
3P Biopharmaceuticals makes a significant donation to help Ukraine
Dámaso Molero, appointed member of the Technical Committee of the Interdepartmental Commission for Personalized Medicine of Navarra.
3P Biopharmaceuticals receives FDA approval
3P Biopharmaceuticals and Buzzard Pharmaceuticals start a cGMP manufacturing collaboration to develop a new treatment to combat solid tumours
Working in biotechnology means working to improve the planet and people’s lives
The University of Navarra and the company 3P Biopharmaceuticals will promote research and talent management in technology and the production of new drugs.
3P Biopharmaceuticals and Invizius hope for reducing the cardiovascular complications associated with dialysis